Silencing of AFAP1-AS1 lncRNA impairs cell proliferation and migration by epigenetically promoting DUSP5 expression in pre-eclampsia.
Shuai ZhangYanfen ZouXiaotong TangYuanyuan ZhangNana YangKun XuYetao XuPublished in: Journal of cellular biochemistry (2021)
As a unique and common obstetric complication of pregnant women, pre-eclampsia (PE) has been the first leading cause of maternal and perinatal morbidity and mortality in the world. Mounting studies have demonstrated that an abnormality of long noncoding RNA (lncRNA) expression was related to the pathological process of PE. Here, we showed that lncRNA AFAP1-AS1 was markedly downregulated in pre-eclamptic placentas. We further investigated the mechanism underlying the regulatory role of AFAP1-AS1 in PE using human trophoblast cells. In vitro functional assays revealed that AFAP1-AS1 knockdown inhibited trophoblast proliferation, migration, and invasion. Moreover, AFAP1-AS1 interacts with EZH2 and inhibits DUSP5 expression through modulating H3K27m3 in the DUSP5 promoter of trophoblast cells, thus being involved in PE pathogenesis. Overall, these findings suggest that AFAP1-AS1 could potentially become a prognostic biomarker as well as a new therapeutic target for PE.
Keyphrases
- long noncoding rna
- pregnant women
- poor prognosis
- induced apoptosis
- long non coding rna
- binding protein
- cell cycle arrest
- signaling pathway
- single cell
- transcription factor
- endothelial cells
- gene expression
- cell therapy
- oxidative stress
- pregnancy outcomes
- body mass index
- physical activity
- high throughput
- pi k akt
- birth weight
- preterm birth